New MRI technology aims to advance neuroimaging and biomarker research CHICAGO--(BUSINESS WIRE)-- GE HealthCare (Nasdaq: GEHC) has received FDA 510(k) clearance for its innovative SIGNA™ MAGNUS,i a ...

Dr. Lena G. Liu (Neurology): A 58-year-old woman was transferred to this hospital because of progressively worsening confusion and evolving changes on magnetic resonance imaging (MRI) of the head. The ...

Toronto, Ontario—A novel imaging approach— 68 Ga-DOTATATE PET/CT—can more accurately differentiate residual/recurrent tumors from post-surgery scar tissue in patients with head and neck paragangliomas ...

The study authors note that the variable nature of physical signs and symptoms in cases of nonaccidental trauma to the head makes empirical neuroimaging a standard requirement to aid in detection.

GE HealthCare has designed a unique head-only MRI it says may expand the field of neuroscience and remove barriers to studying Alzheimer's and psychiatric disease. The Signa Magnus magnetic resonance ...

MRIs are an effective diagnostic tool for pituitary tumors. Although MRI scans can miss very small tumors, newer machines are better equipped to detect them. Most pituitary tumors are noncancerous, or ...

GE Healthcare and Mayo Clinic have won a $5.7 million federal grant to develop a lower-cost, head-only MRI scanner that could handle 25-30 percent of MRI imaging needs, according to a report by DOTmed ...